المؤلفون: Deng YX, Peng JH, Zhao YJ, Sui QQ, Zhao RX, Lu ZH, Qiu MZ, Lin JZ, Pan ZZ

المصدر: Cancer Management and Research, Vol Volume 10, Pp 2083-2094 (2018)

مصطلحات موضوعية: Colorectal cancer, liver metastases, lymph node ratio, N stage, prognosis, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://www.dovepress.com/lymph-node-ratio-as-a-valuable-prognostic-factor-for-patients-with-col-peer-reviewed-article-CMAR; https://doaj.org/toc/1179-1322

URL الوصول: https://doaj.org/article/0f4a85d7616942938b81109f5b83c451

المؤلفون: Di, T, Luo, QY, Song, JT, Yan, XL, Zhang, L, Pan, WT, Guo, Y, Lu, FT, Sun, YT, Xia, ZF, Yang, LQ, Qiu, MZ, Yang, DJ, Sun, J

المصدر: International immunopharmacology. 139:112615

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:159119443

المؤلفون: Yan, HF, Wang, K, Tang, MX, Feng, XH, Trefil, P, Qiu, MZ, Jiang, J

المصدر: Brazilian Journal of Poultry Science. January 2020 22(2)

مصطلحات موضوعية: Air cell, blastoderm, chicken, eggshell windowing, hatchability

وصف الملف: text/html

URL الوصول: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-635X2020000200305

المؤلفون: Yan,HF, Wang,K, Tang,MX, Feng,XH, Trefil,P, Qiu,MZ, Jiang,J

المصدر: Brazilian Journal of Poultry Science, Volume: 22, Issue: 2, Article number: eRBCA-2019-1157, Published: 02 SEP 2020
Brazilian Journal of Poultry Science v.22 n.2 2020
Brazilian Journal of Poultry Science
Fundação APINCO de Ciência e Tecnologia Avícolas (FACTA)
instacron:FACTA

مصطلحات موضوعية: Air cell, chicken, eggshell windowing, hatchability, blastoderm

وصف الملف: text/html

URL الوصول: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::a1913d9362ae5a9fe2c5e8321d5f3fb0
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-635X2020000200305&lng=en&tlng=en

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Liu FR; Department of Clinical Research, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou., Wei XL; Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University, Guangzhou; Research Unit of Precision Diagnosis and Treatment for Gastrointestinal Cancer, Chinese Academy of Medical Sciences, Guangzhou., Feng WN; Department of Pulmonary Oncology, The First People's Hospital of Foshan, Foshan., Zhao HY; Department of Clinical Research, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou., Zhang Y; Department of Clinical Research, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou., Wang ZQ; Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University, Guangzhou; Research Unit of Precision Diagnosis and Treatment for Gastrointestinal Cancer, Chinese Academy of Medical Sciences, Guangzhou., Zhang DS; Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University, Guangzhou; Research Unit of Precision Diagnosis and Treatment for Gastrointestinal Cancer, Chinese Academy of Medical Sciences, Guangzhou., Wang FH; Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University, Guangzhou; Research Unit of Precision Diagnosis and Treatment for Gastrointestinal Cancer, Chinese Academy of Medical Sciences, Guangzhou., Yang S; Department of Pulmonary Oncology, The First People's Hospital of Foshan, Foshan., Pan W; Ascentage Pharma (Suzhou) Co., Ltd., Suzhou, China., Tian X; Ascentage Pharma (Suzhou) Co., Ltd., Suzhou, China., Men L; Ascentage Pharma (Suzhou) Co., Ltd., Suzhou, China., Wang H; Ascentage Pharma (Suzhou) Co., Ltd., Suzhou, China., Liang E; Ascentage Pharma Group Inc., Rockville, USA., Wang C; Ascentage Pharma Group Inc., Rockville, USA., Yang D; Ascentage Pharma (Suzhou) Co., Ltd., Suzhou, China; Department of Experimental Research, State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China., Zhai Y; Ascentage Pharma (Suzhou) Co., Ltd., Suzhou, China; Ascentage Pharma Group Inc., Rockville, USA. Electronic address: yzhai@ascentage.com., Qiu MZ; Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University, Guangzhou; Research Unit of Precision Diagnosis and Treatment for Gastrointestinal Cancer, Chinese Academy of Medical Sciences, Guangzhou. Electronic address: qiumzh@sysucc.org.cn., Xu RH; Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University, Guangzhou; Research Unit of Precision Diagnosis and Treatment for Gastrointestinal Cancer, Chinese Academy of Medical Sciences, Guangzhou. Electronic address: xurh@sysucc.org.cn.

المصدر: ESMO open [ESMO Open] 2024 Aug; Vol. 9 (8), pp. 103651. Date of Electronic Publication: 2024 Jul 25.

نوع المنشور: Journal Article; Clinical Trial, Phase I; Multicenter Study

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

مواضيع طبية MeSH: Neoplasms*/drug therapy , Antibodies, Monoclonal, Humanized*/pharmacology , Antibodies, Monoclonal, Humanized*/therapeutic use, Humans ; Middle Aged ; Male ; Female ; Aged ; Adult ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/pharmacology ; Inhibitor of Apoptosis Proteins/metabolism ; Maximum Tolerated Dose ; Programmed Cell Death 1 Receptor/antagonists & inhibitors ; Pentanoic Acids

المؤلفون: Sun YT; Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University, Guangzhou, 510060, People's Republic of China.; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, People's Republic of China., Lu SX; Department of Pathology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University, Guangzhou, 510060, People's Republic of China., Lai MY; Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University, Guangzhou, 510060, People's Republic of China., Yang X; Department of Pathology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University, Guangzhou, 510060, People's Republic of China., Guan WL; Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University, Guangzhou, 510060, People's Republic of China., Yang LQ; Department of Basic Research, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University, Guangzhou, 510060, People's Republic of China., Li YH; Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University, Guangzhou, 510060, People's Republic of China., Wang FH; Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University, Guangzhou, 510060, People's Republic of China., Yang DJ; Department of Basic Research, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University, Guangzhou, 510060, People's Republic of China. yangdj@sysucc.org.cn., Qiu MZ; Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University, Guangzhou, 510060, People's Republic of China. qiumzh@sysucc.org.cn.

المصدر: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2024 Jun 04; Vol. 73 (8), pp. 144. Date of Electronic Publication: 2024 Jun 04.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE

مواضيع طبية MeSH: Stomach Neoplasms*/drug therapy , Stomach Neoplasms*/metabolism , Stomach Neoplasms*/mortality , Stomach Neoplasms*/pathology , Esophagogastric Junction*/pathology , Esophagogastric Junction*/metabolism , Adenocarcinoma*/drug therapy , Adenocarcinoma*/metabolism , Adenocarcinoma*/mortality , Adenocarcinoma*/pathology , B7-H1 Antigen*/metabolism , B7-H1 Antigen*/antagonists & inhibitors , Biomarkers, Tumor*/metabolism , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Esophageal Neoplasms*/drug therapy , Esophageal Neoplasms*/metabolism , Esophageal Neoplasms*/mortality , Esophageal Neoplasms*/pathology , Immune Checkpoint Inhibitors*/therapeutic use, Humans ; Male ; Female ; Middle Aged ; Aged ; Retrospective Studies ; Adult ; Aged, 80 and over ; Prognosis